熱門資訊> 正文

阿卡迪亚制药将取代独立银行集团成为标准普尔SmallCapital 600指数

2024-12-31 15:35

Acadia Pharmaceuticals (NASDAQ:ACAD) will replace Independent Bank Group (NASDAQ:IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025.
S&P MidCap 400 constituent SouthState (SSB) is acquiring Independent Bank Group (IBTX) in a deal expected to close soon pending final conditions.

More on Acadia Pharma

Acadia: Scope Of Company Goes Beyond Recent SAN711 Licensing Deal For ET
Acadia Pharmaceuticals: Proving The Naysayers Wrong
Acadia closes on $150M FDA voucher sale
Acadia signs licensing deal for essential tremor drug candidate

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。